![]() Samjin Pharmaceutical Samjin Pharmaceutical (삼진제약) is a company that specializes in the drug development area. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1968 | Founding Date 1976 | Founding Date 1978 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 710 | Employees 18,077 | Employees 7,605 |
Financial | |||
Revenue (est.) | Revenue (est.) ₩309.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods ₩165.5b (FY, 2025) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit ₩144.3b (FY, 2025) | Gross profit N/A | Gross profit $7.5b (FY, 2025) |
Net income | Net income ₩24.2b (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products 4 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products 6 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products 11 (FY, 2024) |

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyBiogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company